Products
JRI Limited is a British manufacturer of orthopaedic implants and instrumentation. JRI was formed by Mr Ronald Furlong, FRCS, in 1969 and is renowned for the innovation of the Furlong® H-A.C. Coated Total Hip Replacement, which was the first in the world to apply hydroxy-apatite ceramic to an orthopaedic implant. Today, the Furlong® H-A.C. THR has achieved unparalleled clinical success globally. Thirty percent of the total Company business is export with world-wide distribution.
More information visit www.jri-ltd.co.uk
SAMO was established in 1939 in Bologna, Italy from a branch of the parent company founded in 1895, and since then it is present in the biomedical field as manufacturer of surgical instruments. In the 1950s it became a global provider for any kind of hospital supply, except pharmaceuticals. Later in the 1960s, further to the introduction of new products and technologies, SAMO decided to take on a new strategy focusing on developing joint reconstruction implants and internal fixation products.
For more information please visit www.samobiomedica.com
For over twenty years, Italian owned Tecres has been dealing within the health care industry. The path followed by Tecres differs from that of other companies: The difficulties are that each step and each choice has to do with human suffering and effects on daily life. The spirit inspiring Tecres is their most valuable heritage, which, together with research, has enabled them in twenty years to achieve their prestigious and important objectives.
Tecres orthopaedic products are divided into several lines:
- Cemex: a broad range of bone cements and accessories for all the possibile needs connected with the prostheses fixation.
- Spacer: the solution for hip, knee, shoulder septic revision with the two-stage method.
- Endorthesis screws: a complete range of screws for the treatment of flat footedness. Available in two different versions.
- The Locker: the complete system for the screw-augmentation procedure.
Vancogenx e Vancogenx-Space: Vancomycin and Gentamicin bone cement and spacers.
For more information visit www.tecres.it
The Gore Medical Products Division provides creative healing solutions to complex medical problems. Gore provides such products as bioabsorbable devices, synthetic vascular grafts, interventional devices, endovascular stent-grafts, unique materials for hernia repair, and sutures for use in vascular, cardiac, general surgery and orthopaedic procedures.
Fore more information vist www.goremedical.com
Ulrich medical is an independent, medium-sized and family owned company located in Ulm, Germany. Ulrich successfully markets and distribute innovative medical technology products worldwide. Their success is based on the three major areas:
- Spinal Systems
- Contrast agent injectors CT/MRI
- Surgical Instruments/Tourniquet devices
Spinal Systems – Implants
The implants and instruments for spine surgery by ulrich medical® are used in surgical treatment of injuries and illnesses as well as deformities or degenerative changes in the spinal column.
Their product range includes rod-and-screw systems for the cervical and thoraco-lumbar spine, vertebral body replacement implants and cages for intersomatic fusion, but also dynamic systems for non-fusion stabilisation of the spine.
For more information visit www.ulrichmedical.com
Founded in 2005, Vertiflex Inc is a company dedicated to the advancement of motion preservation and minimally invasive solutions for spinal disorders. Their platform of anatomically driven products offers surgeons the ability to treat a broad range of clinical indications with reduced operating times and minimal trauma to the patient.
With a combination of biomedical engineers, mechanical engineers and other industry professionals, Vertiflex has created a winning team and catapulted to the forefront in spinal offerings of motion preservation and minimally invasive devices.
For more information visit www.vertiflex.net
Reflecting the company’s aggressive strategy to expand the market for its spinal device technology, Raymedica, LLC has unveiled a new corporate identity and brand strategy – Centinel Spine. Designed to better position the company in both existing and new fusion markets and gain further recognition in non-fusion markets, the new corporate identity is the latest step in a series of activities that have resulted in a refined product focus, increased operational efficiency and a clear path to growth in the global spine market.
Centinel Spine is the culmination of Raymedica, LLC corporate transition that began in early 2008 with the merger with Surgicraft Group Holdings Limited, a UK-based medical device company and its subsidiaries (“Surgicraft”). In defining its new corporate identity which addresses 90% of spine pathologies, Centinel Spine conducted extensive research with its Surgeon Advisory Board, management team and partners to build a brand strategy that leverages its reputation for innovation and high quality, as well as highlight its unique collaborative approach in working with surgeons to transform their most ambitious ideas into tomorrow’s technology.
For more information visit www.centinelspine.com
Osteotech, Inc. is a global leader in the processing of human bone and connective tissue for transplantation and an innovator in the development, manufacturing and marketing of biologic, biomaterial and device systems for musculoskeletal surgery. With a particular focus on spinal, trauma, and total joint revision procedures, the Company’s current and development-stage technologies address needs within numerous musculoskeletal disciplines.
Since its formation in 1986, the Company has become the world’s largest processor of aseptic allograft bone tissue yielding over 4.5 million grafts. Used in spinal fusions, to replace cancerous tissue, fill voids caused by trauma, augment prostheses and replace damaged ligaments and tendons, bone tissues processed by Osteotech improve the quality of life for more than 500 transplant recipients every day. In addition, the Company has acquired 90% of OST Developpement in France, which will enable the Company to expand its allograft business throughout Western Europe.
For more information visit www.osteotech.com
Flagship Surgical prides itself on engineering products designed for safety, comfort and efficiency which result in a more focused surgical team and contribute to better patient outcomes during surgical procedures. All of our products are designed in conjunction with world-class surgeons, nurses and operating room technicians who understand the importance of “the optimal surgical suite;” which not only focuses on the patient, but also centers on the most ergonomically designed environment for those performing surgery.
For more information please visit www.flagshipsurgical.com
Medyssey Co., Ltd. is a Korean company specialised in the orthopaedic and neurosurgery fields. Since 2003, Medyssey’s effort has led to rapid growth in both the domestic market and the overseas market with its best top-notched and brand-new unique product line. Medyssey’s accomplishment has been done based on revolutionary products and their tight QC, QM system with accumulated long-term experiences.
For more information please visit www.medyssey.com
MEDICREA is a fully-dedicated spinal implant company focused on introducing reliable and innovative technologies to the global marketplace. With over 18 years of experience, MEDICREA provides a full range of patented products that are conceived, developed and manufactured to advance patient outcomes and support the work of medical professionals.
In a global market that is $6B and growing, MEDICREA distinguishes itself as a comprehensive and responsive business through its extensive and experienced distribution network supported by three wholly-owned subsidiaries in France (Lyon), the United States (New York) and the United Kingdom (Cambridge) and its manufacturing facility located in La Rochelle, France.
MEDICREA builds upon its skilled and dynamic nature by cultivating exciting relationships with highly respected and qualified spine surgeons worldwide to offer a range of products that are distinctively MEDICREA with their innovative technologies leading the market to new levels of functionality, safety and efficacy in spine surgery.
For more information please visit www.medicrea.com
Biocomposites develops, manufactures and markets synthetic calcium composite devices for tissue regeneration. Leading edge, proprietary technologies are bioengineered to mimic in-vivo the composite structure of human bone. Biocomposites’ technologies, developed over more than a decade of research, have been designed by a team of bioceramic and medical polymer specialists with a combined experience of more than fifty years.
Next generation biomaterials such as geneX® and Biosteon® represent a major breakthrough in the treatment of bone disorders and soft tissue injuries, through our developments in the control of surface chemistry to direct cell activity.
Biocomposites’ absorbable devices are used globally by surgeons and clinicians to regenerate bone in fractures, the spine and in cases involving bone loss due to trauma, disease or surgery.
For more information please visit www.biocomposites.com
Exactech, Inc. is an orthopaedic company that develops, manufactures, markets, distributes and sells orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. Founded in 1985 by an orthopaedic surgeon and a biomedical engineer.
Exactech’s main focus is joint replacement systems, including knee, shoulder, and hip implant systems, and distribution of biologic allograft services and bone cement materials used in orthopaedic surgery. They have built their success on customer-centric culture. Feedback and input from their surgeon customers have helped them develop a pipeline of innovative products that improve patient outcomes.
For more information please visit www.exac.com
TranS1®, Inc. is a medical device spine company focused on minimally invasive surgical procedures for the spine, designed to improve patient outcomes and surgical ease-of-use.
Their primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures.
They specialise in bringing innovative spine solutions to market including AxiaLIF and AxiaLIF 2L, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates, low complication rates, and improved patient recovery time.
For more information please visit www.trans1.com
